Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.
Dr. Myles Wolf will lead the institutions’ largest clinical and academic department, overseeing 16 divisions and nearly 2,250 physicians and scientists.
The Fall 2024 Scientific Computing Training Series begins October 2, featuring five webinars on Python, JupyterLab, and R, aimed at enhancing research services and scientific collaboration across all Cornell campuses.
With surprising frequency, patients with severe brain injury can show clear signs of cognitive function on brain scans in response to requests to carry out complex mental work, even when they can’t move or speak.
Britney Schmidt, associate professor of astronomy in the College of Arts and Sciences and of earth and atmospheric sciences in Cornell Engineering, has been named a laureate of the Blavatnik National Awards for Young Scientists.
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators.
Greg Morrisett has been appointed to a second term as the Jack and Rilla Neafsey Dean and Vice Provost of Cornell Tech, Provost Michael I. Kotlikoff announced Oct. 9.
The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.